FDA Inspection
Mipharm S.p.A.Mipharm S.p.A. – FDA Inspection, Sep 22, 2023
Record Details
This FDA Inspection record concerns Mipharm S.p.A., with an inspection on September 22, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · cc148a53-3099-4984-9987-6d1113bbbb60
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1219480
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Mipharm S.p.A.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 17, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 3, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 10, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Mipharm S.p.A.
- FDA Inspection 1133100 - 2019-10-17
- FDA Inspection 1004998 - 2017-02-03
- FDA Inspection 870680 - 2014-02-14
- FDA Inspection 853837 - 2013-09-27
- FDA Inspection 731940 - 2011-06-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.